Standout Papers
Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions
2007
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
2010
Triple-Negative Breast Cancer
2010 Standout
Sun Exposure and Mortality From Melanoma
2005
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Competing risk analysis using R: an easy guide for clinicians
2007
Competing risks analyses: objectives and approaches
2014
Chemoradiotherapy of Locally Advanced Esophageal Cancer
1999 Standout
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
2016
Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank
2019
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
2010 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
1999 Standout
Competing Risk Regression Models for Epidemiologic Data
2009
Vitamin D Deficiency
2007 Standout
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
1996 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions
2013
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
2008
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
High incidence of secondary brain tumours after radiotherapy and antimetabolites
1999
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer
2002 Standout
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Hypertension, Obesity, Diabetes, and Heart Failure–Free Survival
2016
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
Kaplan—meier, marginal or conditional probability curves in summarizing competing risks failure time data?
1993
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
2004 Standout
Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality
2007
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002 Standout
Tutorial in biostatistics: competing risks and multi‐state models
2006 Standout
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
2013
Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
2008
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Regression Modeling of Competing Risks Data Based on Pseudovalues of the Cumulative Incidence Function
2005
Regression modeling of competing risk using R: an in depth guide for clinicians
2010
Testing treatment effects in the presence of competing risks
2005
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Patient death as a censoring event or competing risk event in models of nursing home placement
2009
Assessing the Performance of Prediction Models
2009 Standout
Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial
2008
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
2020
A note on competing risks in survival data analysis
2004
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
2002
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
2012 Standout
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010 Standout
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Prognostic Models With Competing Risks
2009
Quantifying the predictive accuracy of time-to-event models in the presence of competing risks
2011
Evaluating Health Outcomes in the Presence of Competing Risks
2010
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
2017
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
2017
Clinical states of cirrhosis and competing risks
2017
Dietary polyamine intake and colorectal cancer risk in postmenopausal women
2015
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
2012
Actual and Actuarial Probabilities of Competing Risks: Apples and Lemons
2007
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Competing Risk of Death: An Important Consideration in Studies of Older Adults
2010
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Hepatocellular Carcinoma
2019 Standout
Microsatellite Instability and Epigenetic Inactivation of MLH1 and Outcome of Patients With Endometrial Carcinomas of the Endometrioid Type
2007
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
2011
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
2011
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
2016 Standout
Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610
2008
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
2008
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Choice and Interpretation of Statistical Tests Used When Competing Risks Are Present
2008
Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
2013
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
2009
On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data
1993
A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer
2004 Standout
Spermidine in health and disease
2018 StandoutScience
Competing risks and the clinical community: irrelevance or ignorance?
2011
Survival After Bilateral Versus Single-Lung Transplantation for Idiopathic Pulmonary Fibrosis
2009
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function
2018
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
2018 Standout
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2005
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
2002 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
2012 Standout
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
2015 Standout
Competing Risks and Multistate Models with R
2011
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Works of Malcolm H. Ray being referenced
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
1988 Standout
A Proportional Hazards Model for the Subdistribution of a Competing Risk
1999 Standout